Combined modality therapy for pancreatic cancer

Seminars in Oncology

Volumn 30, Issue 4 SUPPL. 9, 2003, Pages 71-79

  Tsai, James Y ^b   Iannitti, David A ^b   Safran, Howard ^a  

^a MIRIAM HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; PACLITAXEL;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; MULTIMODALITY CANCER THERAPY; PANCREAS CANCER; PANCREAS SURGERY; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; REVIEW;

EID: 0043238694     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(03)00273-2     Document Type: Article

References (49)

1. Jemal A, Murray T, Samuels A, et al: Cancer statistics, 2003. CA Cancer J Clin 53:5-26, 2003
2. Wagman R, Crann A: Adjuvant therapy for pancreatic cancer: Current treatment approaches and future challenges. Surg Clin North Am 81:667-681, 2001
3. Moertel CG, Frytak S, Hahn RG, et al: Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 48:1705-1710, 1981
4. Gastrointestinal Tumor Study Group: Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 80:751-755, 1988
5. Klaassen DJ, MacIntyre JM, Catton GE, et al: Treatment of locally unresectable cancer of the stomach and pancreas: A randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil-An Eastern Cooperative Oncology Group study. J Clin Oncol 3:373-378, 1985
6. O'Connell MJ, Marteson JA, Wieand HS, et al: Improving adjuvant therapy for rectal cancer by combining protracted venous infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507, 1994
7. Whittington R, Neuberg D, Tester WJ, et al: Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: A phase I Eastern Cooperative Oncology Group Trial. J Clin Oncol 13:227-232, 1995
8. Willett CG, Safran H, Abrams RA, et al: Clinical research in pancreatic cancer: The Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 2003 (in press)
9. Burris HA III, Moore MJ, Andersen J, et al: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 15:2403-2413, 1997
10. Shewach DS, Lawrence TS: Radiosensitization of human tumor cells by gemcitabine in vitro. Semin Oncol 22:68-71, 1995
11. Ostruszka LJ, Schewach DS: The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine. Cancer Res 60:6080-6088, 2000
12. Lawrence TS, Chang EY, Hahn TM, et al: Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int J Radiat Oncol Biol Phys 34:867-872, 1996
13. Blackstock AW, Bernard SA, Richards F, et al: Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J Clin Oncol 17: 2208-2212, 1999
14. Blackstock AW, Tempero MA, Niedwiecki D, et al: Cancer and Leukemia Group B (CALGB) 89805: Phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas. Proc Am Soc Clin Oncol 20:158a, 2001 (abstr 627)
15. Hoffman JP, McGinn CJ, Szarka C, et al: A phase I study of preoperative gemcitabine (GEM) with radiation therapy (RT) followed by postoperative GEM for patients with localized, resectable pancreatic adenocarcinoma (PaC). Proc Am Soc Clin Oncol 17:283a, 1998 (abstr 1090)
16. McGinn CJ, Zalupski MM, Shureiqi I, et al: Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol 19:4202-4208, 2001
17. Talamonti MS, Catalano PJ, Vaughn DJ, et al: Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity. J Clin Oncol 18:3384-3389, 2000
18. Osteen RT, Zinner MJ, Fuchs CS, et al: Phase I trial of concurrent gemcitabine (GEM), infusional 5 fluorouracil (FU) and radiation therapy (RT) in patients with localized, unresectable pancreatic adenocarcinoma (PAC). Proc Am Soc Clin Oncol 18:284a, 1999 (abstr 1091)
19. Philip PA, Zalupski MM, Baitkevicius VK, et al: Phase II study of gemcitabine and cisplatin in treatment of patients with advanced pancreatic carcinoma. Cancer 92:569-577, 2001
20. Ko AH, Tempero MA: Current and future strategies for combined-modality therapy in pancreatic cancer. Curr Oncol Rep 4:202-212, 2002
21. Colucci G, Giuliani F, Gebbia V, et al: Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: A prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale. Cancer 94:902-910, 2002
22. Martenson JA, Vigliotti AG, Pitot HC, et al: Phase I study of twice weekly gemcitabine (GEM) and cisplatin (CDDP) during radiation therapy (RT) for locally advanced pancreas and gastric cancer. Proc Am Soc Clin Oncol 21:146a, 2002 (abstr 583)
23. Aitken CL, Safar AM, Recht A, et al: Phase I trial of gemcitabine, cisplatin (CDDP) and external beam radiation therapy (EBRT) for pancreatic cancer. Proc Am Soc Clin Oncol 21:102b, 2002 (abstr 2221)
24. Choy H, Rodriguez FF, Koester S, et al: Investigation of taxol as a potential radiation sensitizer. Cancer 71:3774-3778, 1993
25. Whitehead RP, Jacobson J, Brown TD, et al: Phase II trial of paclitaxel and granulocyte colony-stimulating factor in patients with pancreatic carcinomas: A Southwest Oncology Group study. J Clin Oncol 15:2414-2419, 1997
26. Liebmann J, Cook JA, Fisher J, et al: In vitro studies of taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst 86:441-446, 1994
27. Choy H, Akerley W, Safran H, et al: A phase I trial of concurrent weekly taxol administered as a 3 hour infusion and radiation therapy for advanced non-small cell lung cancer. J Clin Oncol 12:2682-2686, 1994
28. Choy H, Akerley W, Safran H, et al: Multiinstitutional phase II trial of paclitaxel, carboplatin and concurrent radiation therapy for locally advanced non-small cell lung cancer. J Clin Oncol 16:3316-3322, 1998
29. Milross CG, Mason KA, Hunter NR, et al: Enhanced radioresponse of paclitaxel-sensitive and -resistant tumors in vivo. Eur J Cancer 33:1299-1308, 1997
30. Safran H, King TP, Choy H, et al: Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: A phase I study. J Clin Oncol 15:901-907, 1997
31. Safran H, Moore T, Iannitti D, et al: Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 49:1275-1279, 2001
32. Rich T, Harris J, Abrams R, et al: A phase II study of external irradiation and weekly paclitaxel for non-metastatic, unresectable pancreatic cancer: A preliminary report of RTOG protocol 98-12. Int J Radiat Oncol Biol Phys 51:26, 2001 (suppl 1) (abstr 4)
33. Safran H, DiPetrillo T, Iannitti D, et al: Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: A phase I trial. Int J Radiat Oncol Biol Phys 54:137-141, 2002
34. Jessup JM, Steele G, Mayer RJ, et al: Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 128:559-564, 1993
35. White R, Lee C, Anscher M, et al: Preoperative chemoradiation for patients with locally advance adenocarcinoma of the pancreas. Ann Surg Oncol 6:38-45, 1999
36. Bajetta E, DiBartiolomeo M, Stani SC, et al: Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: Results of a feasibility study. Int J Radiat Oncol Biol Phys 45:285-289, 1999
37. Kalser MH, Ellenberg SS: Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899-903, 1985
38. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59: 2006-2010, 1987
39. Klinkenbijl JH, Jeeke J, Sahmoud T, et al: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776-784, 1999
40. Neoptolemos JP, Dunn JA, Stocken DD, et al: Adjuvant chemoradiotherapy and chemotherapy in respectable pancreatic cancer: A randomized controlled trial. Lancet 358:1576-1585, 2001
41. Abrams RA, Lillemoe KD, Piantadosi S: Continuing controversy over adjuvant therapy of pancreatic cancer. Lancet 358:1565-1566, 2001
42. Evans DB, Wolff RA, Crane CG: Neoadjuvant strategies for pancreatic cancer. Oncology 15:727-737, 2001
43. Ishikawa O, Ohhigashi H, Teshima T, et al: Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreaticoduodenal region. J Surg Oncol 40:143-151, 1989
44. Evans DB, Rich TA, Byrd DR, et al: Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127:1335-1339, 1992
45. Hoffman JP, Weese JL, Solin LJ, et al: A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg 169:71-78, 1995
46. Hoffman JP, Lipsitz S, Pisansky T, et al: Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group study. J Clin Oncol 16:317-323, 1998
47. Pister PWT, Abbruzzese JL, Janjan NA, et al: Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol 16:3843-3850, 1998
48. Breslin TM, Hess KR, Harbison DB, et al: Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration. Ann Surg Oncol 8:123-132, 2001
49. Wolff RA, Evans DB, Crane CH, et al: Initial results of preoperative gemcitabine (GEM)-based chemoradiation for resectable pancreatic adenocarcinoma. Proc Am Soc Clin Oncol 21:130a, 2002 (abstr 516)